PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAxsome Therapeutics
Axsome Therapeutics(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AuvelityDextromethorphan, Bupropion2022-08-182023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Toothache
,
Dysmenorrhea
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine without aura
,
migraine with aura
,
vertigo
,
recurrence
,
migraine disorders
,
headache
,
epilepsy
,
stroke
,
brain neoplasms
,
parkinson disease
,
multiple sclerosis
,
restless legs syndrome
,
post-concussion syndrome
,
cognitive dysfunction
,
post-traumatic headache
,
motion sickness
,
cardiovascular diseases
,
pregnancy
Dextromethorphan
healthy volunteers/patients
,
drug interactions
,
schizophrenia
,
treatment-resistant depressive disorder
,
dementia
,
alzheimer disease
,
psychomotor agitation
Bupropion
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
alzheimer disease
,
dementia
,
psychomotor agitation
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depression
,
depressive disorder
,
recurrence
Meloxicam
migraine disorders
Bupropion hydrochloride
tobacco use disorder
,
cigarette smoking
,
smoking cessation
,
alzheimer disease
,
dementia
,
psychomotor agitation
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depression
,
depressive disorder
,
recurrence
Glutamic acid
schizophrenia
,
psychotic disorders
Doconexent
melanoma
,
uveal neoplasms
Esreboxetine
hyperalgesia
,
fibromyalgia
Reboxetine
sleepiness
,
narcolepsy
,
cataplexy
,
disorders of excessive somnolence
D-glutamate
depression
,
major depressive disorder
,
depressive disorder
,
treatment-resistant depressive disorder
Buproprion
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
Nicoderm
failure to thrive
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use